STAT February 14, 2025
Happy V-Day! Gorge on heart-shaped chocolate and ponder the implications of RFK Jr. being sworn in as health secretary. Today, we talk about that, as well as new cancer data from Corbus Pharma, Europe’s reaction to talk of an academic brain drain in the U.S., and more.
The need-to-know this morning
- Moderna missed earnings forecasts, posting a net loss of $1.1 billion, or $2.91 per share, 23% below the expectations of analysts polled by Visible Alpha. Revenue was 4% higher than forecasts, mostly due to higher than expected sales of Moderna’s Covid vaccine, SpikeVax. In January, the company cut its...
Today's Sponsors
Today's Sponsor